Differentiation of tubular and villous adenomas based on Wnt pathway-related gene expression profiles

International Journal of Molecular Medicine

Volumn 26, Issue 1, 2010, Pages 121-125

  Nguyen, Anthony V ^a   Albers, C Gregory ^b   Holcombe, Randall F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenoma; c myc; Gene expression; Stroma; Wnt signaling

Indexed keywords

BETA CATENIN; CSNK2A2 PROTEIN; CXXC4 PROTEIN; DAAM1 PROTEIN; DAMM2 PROTEIN; FRAT2 PROTEIN; FZ2 PROTEIN; MYC PROTEIN; NLK PROTEIN; PYGO1 PROTEIN; PYGO2 PROTEIN; RHO U PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN;

ADENOMATOUS POLYP; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; STROMA; TUMOR DIFFERENTIATION; VILLOUS ADENOMA;

EID: 77954736347     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000443     Document Type: Article

References (32)

1. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
2. Lieberman DA and Smith FW: Screening for colon malignancy with colonoscopy. Am J Gastroenterol 86: 946-951, 1991.
3. Winawer SJ and Zauber AG: The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am 12: 1-9, 2002.
4. Holcombe RF, Marsh JL, Waterman ML, Lin F, Milovanovic T and Truong T: Expression of Wnt ligands and Frizzled receptors in colonic mucosa and in colon cancer. Mol Pathol 55: 220-226, 2002.
5. Suzuki H, Watkins DN, Jair K-W, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, van Engeland M, Toyota M, Tokino T, Hinoda Y, Imai K, Herman JG and Baylin SB: Epigenetic inactivation of SFRP genes allows constitutive Wnt signaling in colorectal cancer. Nat Genet 36: 417-422, 2004.
6. Taketo MM: Shutting down Wnt signal-activated cancer. Nat Genet 36: 320-322, 2004.
7. Phelps RA, Chidester S, Dahghanizadeh S, Phelps J, Sandoval IT, Rai K, Broadbent T, Sarkar S, Burt RW and Jones DA: A two step model for colon adenoma initiation and progression caused by APC loss. Cell 137: 623-634, 2009.
8. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J and Wang CY: Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Bio 152: 87-96, 2001.
9. Schweizer L and Varmus H: Wnt/Wingless signaling through beta-catenin requires the function of both LRP/Arrow and frizzled classes of receptors. BMC Cell Bio 4: 4, 2003.
10. Wang S and Jones KA: CK2 controls the recruitment of Wnt regulators to target genes in vivo. Curr Biol 16: 2239-2244, 2006.
11. Bek S and Kemler R: Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability. J Cell Sci 115: 4743-4753, 2002.
12. Jessen S, Gu B and Dai X: Pygopus and the Wnt signaling pathway: A diverse set of connections. Bioessays 30: 448-456, 2008.
13. Andrews PG, Lake BB, Popadiuk C and Kao KR: Requirement of pygopus 2 in breast cancer. Int J Oncol 30: 357-363, 2007.
14. Schwab KR, Patterson LT, Hartman HA, Song N, Lang RA, Lin X and Potter SS: Pygo1 and pygo2 roles in Wnt signaling in mammalian kidney development. BMC Biol 5: 15, 2007.
15. Stoothoff WH, Cho JH, McDonald RP and Johnson GV: FRAT-2 preferentially increases glycogen synthase kinase 3 betamediated phosphorylation of primed sites, which results in enhanced tau phosphorylation. J Biol Chem 280: 270-276, 2005.
16. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1438-1441, 1998.
17. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M and Park M: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527, 2008. (Pubitemid 351655218)
18. Finley GG, Schulz NT, Hill SA, Geiser JR, Pipas JM and Meisler AI: Expression of the myc gene family in different stages of human colorectal cancer. Oncogene 4: 963-971, 1989. (Pubitemid 19202811)
19. Melhem MF, Meisler AI, Finley GG, Bryce WH, Jones MO, Tribby II, Pipas JM and Koski RA: Distribution of cells expressing myc proteins in human colorectal epithelium, polyps and malignant tumors. Cancer Res 52: 5833-5864, 1992.
20. Imaseki H, Hayashi H, Taira M, Ito Y, Tabata Y, Onoda S, Isono K and Tatibana M: Expression of c-myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential. Cancer 64: 704-709, 1989.
21. Sundaresan V, Forgacs IC, Wight DGD, Wilson B, Evan GI and Watson JV: Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis. J Clin Path 40: 1274-1281, 1987.
22. Wang HL, Wang J, Xiao SY, Stoiber D, He TC, Bissonnette M and Hart J: Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer 101: 301-310, 2002.
23. Huang H and He X: Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20: 119-125, 2008.
24. Li Q, Dashwood WM, Zhong X, Al-Fageeh M and Dashwood RH: Cloning of the rate beta-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 83: 231-242, 2004.
25. Katoh M: Wnt/PCP signaling pathway and human cancer. Oncol Rep 14: 1583-1588, 2005.
26. Smit L, Baas A, Kuipers J, Korswagen H, van de Wetering M and Clevers H: Wnt activates the Tak1/Nemo-like kinase pathway. J Biol Chem 279: 17232-1740, 2004.
27. Yamada M, Ohnishi J, Ohkawara B, Iemura S, Satoh K, Hyodo-Miura J, Kawachi K, Natsume T and Shibuya H: NARF, a nemo-like kinase (NLK)-associated ring finger protein regulates the ubiquitylation and degradation of T cell factor/lymphoid enhancer factor (TCF/LEF). J Biol Chem 281: 20749-20760, 2006.
28. Habas R and He X: Activation of Rho and Rac by Wnt/frizzled signaling. Methods Enzymol 406: 500-511, 2006.
29. Aspenstroem P, Richnau N and Johansson AS: The diaphanous-related formin DAAM1 collaborates with the Rho GTPases RhoA and Cdc42, CIP4 and Src in regulating cell morphogenesis and actin dynamics. Exp Cell Res 312: 2180-2194, 2006.
30. Ishikawa A, Kitajima S, Takahashi Y, Kokubo H, Kanno J, Inoue T and Saga Y: Mouse NKD1, a Wnt antagonist, exhibits oscillatory gene expression in the PSM under the control of Notch signaling. Mech Dev 121: 1443-1453, 2004.
31. Van Raay TJ, Coffey RJ and Solnica-Krezel L: Zebrafish naked1 and naked2 antagonize both canonical and non-canonical Wnt signaling. Dev Biol 309: 151-168, 2007.
32. Caldwell GM, Jones CE, Soon Y, Warrack R, Morton DG and Matthews GM: Reorganization of Wnt-response pathways in colorectal tumorigenesis. Br J Cancer 98: 1437-1442, 2008.